title: Chronic kidney disease in postmenopausal women.
abstract: Menopause is derived from the Greek words men (month) and pauses (cessation) and means permanent cessation of menstruation after the loss of ovarian activity. Chronic kidney disease (CKD) has recently been associated with cardiovascular events in several studies. CKD patients have a heavy burden of traditional cardiovascular risk factors in addition to a range of nontraditional risk factors such as inflammation and abnormal metabolism of calcium and phosphate. In this review, the association of CKD and cardiovascular disease (CVD), as well as of osteoporosis in postmenopausal women is discussed. CKD mineral and bone disorder, characterized by disturbances of calcium/phosphate/parathyroid hormone, bone abnormalities and vascular and soft tissue calcification, is highly prevalent in CKD and is a strong, independent predictor of bone fracture, CVD and death. Estrogen has been shown to: (a) decrease the expression of angiotensin type 1 receptors in vasculature and kidneys; (b) reduce the expression and activity of angiotensin-converting enzyme, and (c) cause the release of angiotensinogen substrate from the liver. However, the degree of activation or suppression of the renin-angiotensin-aldosterone system by estrogen has not been clearly established. Clinical data on the effects of estrogen therapy on bone mineral densities are extremely limited in the ESRD population. CVD is the most common cause of death in postmenopausal women with CKD and many contributing factors have been explored. Future research for prevention of CVD in postmenopausal women with CKD would focus on the biology of vascular calcification as well as bone loss.
authors: Department of Nephrology, Saitama Medical University, Iruma gun, Saitama, Japan. iromichi@saitama-med.ac.jp
authors: Hiromichi
authors: H
authors: Suzuki
authors: Kazuoki
authors: K
authors: Kondo
mesh_terms: D000368:Aged; D001847:Bone Diseases / Q000150:complications / Q000453:epidemiology; D002908:Chronic Disease; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000502:physiology; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000453:epidemiology*; D008875:Middle Aged; D017698:Postmenopause / Q000502:physiology*
chemical_list: D004967:Estrogens